Home › Kanser sa Atay (Hepatocellular Carcinoma)
Pag-aaral pangklinika para sa Kanser sa Atay (Hepatocellular Carcinoma) na nagre-recruit sa U.S.
131 pag-aaral para sa Kanser sa Atay (Hepatocellular Carcinoma) ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX31 pag-aaral
- New York City, NY24 pag-aaral
- Dallas, TX19 pag-aaral
- Los Angeles, CA19 pag-aaral
- Boston, MA18 pag-aaral
- Cleveland, OH18 pag-aaral
- Philadelphia, PA16 pag-aaral
- Chicago, IL16 pag-aaral
- Pittsburgh, PA15 pag-aaral
- San Francisco, CA14 pag-aaral
- Orange, CA14 pag-aaral
- Jacksonville, FL14 pag-aaral
- San Antonio, TX13 pag-aaral
- St. Louis, MO13 pag-aaral
- Rochester, MN12 pag-aaral
- Detroit, MI11 pag-aaral
- Baltimore, MD11 pag-aaral
- Portland, OR11 pag-aaral
- Atlanta, GA11 pag-aaral
- Seattle, WA10 pag-aaral
- Nashville, TN10 pag-aaral
- Washington, DC10 pag-aaral
- Mountain View, CA10 pag-aaral
- Arlington, VA9 pag-aaral
- Baldwin Park, CA9 pag-aaral
- Ann Arbor, MI9 pag-aaral
- Birmingham, AL8 pag-aaral
- Milwaukee, WI8 pag-aaral
- Durham, NC8 pag-aaral
- Santa Monica, CA8 pag-aaral
- San Diego, CA8 pag-aaral
- Scottsdale, AZ7 pag-aaral
- Omaha, NE7 pag-aaral
- Tampa, FL7 pag-aaral
- Phoenix, AZ7 pag-aaral
- Miami, FL7 pag-aaral
- Irvine, CA6 pag-aaral
- New Haven, CT6 pag-aaral
- Tucson, AZ6 pag-aaral
- Aurora, CO6 pag-aaral
Ayos sa estado
- Alabama9 pag-aaral
- Arizona17 pag-aaral
- California54 pag-aaral
- Colorado11 pag-aaral
- Connecticut8 pag-aaral
- Delaware3 pag-aaral
- District of Columbia4 pag-aaral
- Florida27 pag-aaral
- Georgia12 pag-aaral
- Hawaii3 pag-aaral
- Illinois20 pag-aaral
- Indiana5 pag-aaral
- Iowa3 pag-aaral
- Kentucky6 pag-aaral
- Louisiana5 pag-aaral
- Maryland16 pag-aaral
- Massachusetts19 pag-aaral
- Michigan20 pag-aaral
- Minnesota21 pag-aaral
- Missouri14 pag-aaral
- Nebraska8 pag-aaral
- Nevada4 pag-aaral
- New Hampshire3 pag-aaral
- New Jersey10 pag-aaral
- New York33 pag-aaral
- North Carolina11 pag-aaral
- Ohio23 pag-aaral
- Oklahoma5 pag-aaral
- Oregon11 pag-aaral
- Pennsylvania27 pag-aaral
- Rhode Island3 pag-aaral
- South Carolina6 pag-aaral
- Tennessee14 pag-aaral
- Texas50 pag-aaral
- Utah5 pag-aaral
- Virginia17 pag-aaral
- Washington15 pag-aaral
- Wisconsin12 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
The Vanguard Study: Testing a New Way to Screen for Cancer
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06995898A Study of ZW251 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07164313Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT03942328Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06265285A Phase 1 Study of the Safety and Tolerability of CTX-10726
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07419841Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT05176483The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07285044Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06726161Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07227012National Liver Cancer Screening Trial
Nagre-recruitPhase 4
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06084234A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07291076Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06915753Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
Nagre-recruitPhase 2
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07219459A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Nagre-recruitPhase 1
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06066138GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
Nagre-recruitMaagang Phase 1
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07627191A Study Evaluating a New Radiation Treatment Workflow (NGDS)
Nagre-recruit
Edad 21 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07824583A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT06427941Defining the Ablative Dose for Y-90 TARE
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07586046A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06007846Evaluating Novel Therapies in ctDNA Positive GI Cancers
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT05482516Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT04380545Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Nagre-recruitObservasyonal na pag-aaral
Edad 22 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06486454GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT04864054Adjuvant IP-001 Treatment for HCC Patients Following Surgical Resection and Ablation or Ablation Alone
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT06526338Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06811116Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.